Literature DB >> 23529163

High blood pressure and cerebral white matter lesion progression in the general population.

Benjamin F J Verhaaren1, Meike W Vernooij, Renske de Boer, Albert Hofman, Wiro J Niessen, Aad van der Lugt, M Arfan Ikram.   

Abstract

High blood pressure is considered an important risk factor for cerebral white matter lesions (WMLs) in the aging population. In a longitudinal population-based study of 665 nondemented persons, we investigated the longitudinal relationship of systolic blood pressure, diastolic blood pressure, and pulse pressure with annual progression of WMLs. Means of blood pressure were calculated over a 5-year period before longitudinal MRI scanning. WML progression was subsequently measured on 2 scans 3.5 years apart. We performed analyses with linear regression models and evaluated adjustments for age, sex, cardiovascular risk factors, and baseline WML volume. In addition, we evaluated whether treatment of hypertension is related to less WML progression. Both systolic and diastolic blood pressures were significantly associated with annual WML progression (regression coefficient [95% confidence interval], 0.08 [0.03; 0.14] mL/y and 0.09 [0.03; 0.15] mL/y per SD increase in systolic and diastolic blood pressure, respectively). Pulse pressure was also significantly associated with WML progression, but not independent from hypertension. After adjustment for baseline WML volume, only systolic blood pressure remained significantly associated: 0.05 (0.00; 0.09) mL/y per SD increase. People with uncontrolled untreated hypertension had significantly more WML progression than people with uncontrolled treated hypertension (difference [95% confidence interval], 0.12 [0.00; 0.23] mL/y). The present study further establishes high blood pressure to precede WMLs and implies that hypertension treatment could reduce WML progression in the general population.

Entities:  

Keywords:  aging; blood pressure; epidemiology; hypertension; pulse pressure; white matter lesions/hyperintensities

Mesh:

Year:  2013        PMID: 23529163     DOI: 10.1161/HYPERTENSIONAHA.111.00430

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  74 in total

Review 1.  Small vessel disease and memory loss: what the clinician needs to know to preserve patients' brain health.

Authors:  Christian Schenk; Timothy Wuerz; Alan J Lerner
Journal:  Curr Cardiol Rep       Date:  2013-12       Impact factor: 2.931

2.  Two-kidney one-clip is a pertinent approach to integrate arterial hypertension in animal models of stroke: Serial magnetic resonance imaging studies of brain lesions before and during cerebral ischemia.

Authors:  Benjamin Ménard; Laurent Chazalviel; Simon Roussel; Myriam Bernaudin; Omar Touzani
Journal:  J Cereb Blood Flow Metab       Date:  2017-06-15       Impact factor: 6.200

Review 3.  Subclinical Cerebrovascular Disease: Epidemiology and Treatment.

Authors:  Adam de Havenon; Chelsea Meyer; J Scott McNally; Matthew Alexander; Lee Chung
Journal:  Curr Atheroscler Rep       Date:  2019-07-27       Impact factor: 5.113

4.  Systolic inter-arm blood pressure difference and risk of cognitive decline in older people: a cohort study.

Authors:  Christopher E Clark; Daniel Thomas; David J Llewellyn; Luigi Ferrucci; Stefania Bandinelli; John L Campbell
Journal:  Br J Gen Pract       Date:  2020-06-25       Impact factor: 5.386

Review 5.  Cardiovascular risk factors and small vessel disease of the brain: Blood pressure, white matter lesions, and functional decline in older persons.

Authors:  Hazel Mae A Abraham; Leslie Wolfson; Nicola Moscufo; Charles R G Guttmann; Richard F Kaplan; William B White
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

Review 6.  Binswanger's disease: toward a diagnosis agreement and therapeutic approach.

Authors:  Branko N Huisa; Gary A Rosenberg
Journal:  Expert Rev Neurother       Date:  2014-09-09       Impact factor: 4.618

Review 7.  Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: A systematic review and meta-analysis.

Authors:  Thomas T van Sloten; Athanase D Protogerou; Ronald M A Henry; Miranda T Schram; Lenore J Launer; Coen D A Stehouwer
Journal:  Neurosci Biobehav Rev       Date:  2015-03-28       Impact factor: 8.989

Review 8.  Promoting Successful Cognitive Aging: A Ten-Year Update.

Authors:  Taylor J Krivanek; Seth A Gale; Brittany M McFeeley; Casey M Nicastri; Kirk R Daffner
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 9.  White matter hyperintensities, cognitive impairment and dementia: an update.

Authors:  Niels D Prins; Philip Scheltens
Journal:  Nat Rev Neurol       Date:  2015-02-17       Impact factor: 42.937

Review 10.  Diabetic Microvascular Disease: An Endocrine Society Scientific Statement.

Authors:  Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini
Journal:  J Clin Endocrinol Metab       Date:  2017-12-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.